Table 11. Summary of HIEPC-related procedures in different PC institutions or countries (published researches).
| Country /No. Institutions |
Major Institutions | No. patients | Mode | HIPEC-MMC alone | HIPEC-MMC+DDP | HIPEC-L-OHP alone | HIPEC-other | Temperature (°C) |
Duration (min) |
|---|---|---|---|---|---|---|---|---|---|
| USA, 17 | Wake Forest University of Baptist Medical Center [13, 20, 68, 76, 86, 87] | ||||||||
| Subtotal/Median/Range | >709 | C | 30 mg | 40.75 (38.5-43) | 90 (60-90) | ||||
| University of Pittsburgh Medical Center (University of Pittsburgh) [37, 52, 56, 88] | |||||||||
| Subtotal/Median/Range | 190 | C | 40 mg | 42 (40-42) | 100 (90-100) | ||||
| Washington Hospital Center [13, 43, 55] | |||||||||
| Subtotal/Median/Range | >81 | C | 10 or 12.5 mg/m2 | 42 (40-43) | 90 (30-90) | ||||
| Cancer Treatment Centers of America [29, 72] | |||||||||
| Subtotal/Median/Range | ? | O/C | Y | Y | 40-43 | 30-120 | |||
| Loma Linda University Medical Center [29, 72] | |||||||||
| Subtotal/Median/Range | ? | O/C | Y | Y | 40-43 | 30-120 | |||
| Medical College of Wisconsin [29, 72] | |||||||||
| Subtotal/Median/Range | ? | O/C | Y | Y | 40-43 | 30-120 | |||
| Mercy Medical Center [29, 72] | |||||||||
| Subtotal/Median/Range | ? | O/C | Y | Y | 40-43 | 30-120 | |||
| Moores Cancer Center, University of California [29, 72] | |||||||||
| Subtotal/Median/Range | ? | O/C | Y | Y | 40-43 | 30-120 | |||
| Rutgers University [29, 72] | |||||||||
| Subtotal/Median/Range | ? | O/C | Y | Y | 40-43 | 30-120 | |||
| St Agnes Hospital [15, 34] | |||||||||
| Subtotal/Median/Range | >30 | O/C | 10-20 mg/m2 | 42 | 90 | ||||
Note: C: closed abdomen technique for HIPEC; O: open abdomen technique for HIPEC; Y: yes; MMC: mitomycin C; DDP: cisplatin; 5-FU: fluorouracil; L-OHP: oxaliplatin; CPT-11: irinotecan